Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 131.58 million as of June 5, 2025. Its market cap has decreased by -22.44% in one year.

Market Cap

131.58M

Enterprise Value

165.92M

Revenue

42.50M

Ranking

n/a

PE Ratio

10.04

Stock Price

7.80

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 130.73M to 131.58M, an increase of 0.65%. That is a compound annual growth rate of 0.04%.

Market Cap History

Date	Market Cap	% Change
Jun 3, 2025	130.71M	-14.81%
Dec 30, 2024	153.44M	86.31%
Dec 29, 2023	82.36M	231.73%
Dec 30, 2022	24.83M	5.96%
Dec 30, 2021	23.43M	-26.63%
Dec 30, 2020	31.94M	-64.16%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	166.23B
GSK plc	61.11B
Haleon	37.26B
Smith & Nephew	9.40B
ConvaTec Group	5.92B
Hikma Pharmaceuticals	4.72B
HUTCHMED (China)	1.77B
Genus	1.32B

Market Cap Rankings